7 Products Boston Scientific is Betting on in 2014: Watchman Left Atrial Appendage Closure Device

Watchman Left Atrial Appendage Closure Device Back in December, the Watchman received a favorable FDA panel vote, with the advisory committee voting 13-1 that the device’s benefits outweigh the risks, that it provides reasonable assurance of efficacy, and that there is reasonable assurance that it is safe. Mahoney said the company expects FDA approval of the device in the first half of this year.

Watchman Left Atrial Appendage Closure Device

Back in December, the Watchman received a favorable FDA panel vote, with the advisory committee voting 13-1 that the device’s benefits outweigh the risks, that it provides reasonable assurance of efficacy, and that there is reasonable assurance that it is safe. Mahoney said the company expects FDA approval of the device in the first half of this year. 

SynergyLotus

 

 

 

[image courtesy of BOSTON SCIENTIFIC]

Filed Under
500 characters remaining